Fluorescently labeled PBAE nanoparticles with either CMV-Fzd4 (nano-Fzd4) or CMV-Empty (nano-Empty) plasmids were delivered intravenously to tumor-bearing mice one week after implantation of LLC tumor cells (Fig. 7A). This evidence concerns the gene FZD4 and neoplasm.